LifeMD, Inc. · NASDAQ:LFMD

LifeMD — Investor Presentation (February 2021)

25 slides from LifeMD's investor presentation, February 2021

  1. Slide 1: Radically Changing Healthcare with State-of-the-Art Direct-to-Consumer Telemedicine

    Radically Changing Healthcare with State-of-the-Art Direct-to-Consumer Telemedicine February 2021 NASDAQ : LFMD

  2. Slide 2: Important Cautions Regarding Forward-Looking Statements

    Important Cautions Regarding Forward-Looking Statements NASDAQ:LFMD Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward- looking statements are made pursuant to the Securities Litigation Refor

  3. Slide 3: LifeMD At a Glance

    LifeMD At a Glance NASDAQ:LFMD Radically Changing Healthcare with Disruptive Technology Platform and Premier Brands $38M 205% 525% 2020P Revenue1 2020P Revenue Growth1 2020P Growth in Annual Recurring Revenue2 $600B+ 250,000+ 50 State Near-Term Total Patients & Customers3 Physician Coverage Addressa

  4. Slide 4: Who We Are

    Who We Are NASDAQ:LFMD § LifeMD is a leader in direct-to-patient telehealth. § We provide a seamless, end-to-end virtual healthcare solution to patients across all 50 states. § Full range of subscription-based proprietary telehealth products & services: § Rex MD™ - telehealth for men. § Shapiro MD™

  5. Slide 5: Corporate Highlights

    Corporate Highlights NASDAQ:LFMD Emerging Leader in DTC Healthcare Delivered via Telemedicine Massive, largely unpenetrated $600 billion total addressable market with strong industry tailwinds. Expanding portfolio of leading direct-to-consumer healthcare brands. Highly scalable, proprietary technolo

  6. Slide 6: Large Market Opportunity

    Large Market Opportunity NASDAQ:LFMD Massive Industry Shift Creating Significant ‘White Space’ $175B x 3.9 70% <10% $45B 2019 2026 Retail Prescription Drug Market Online Pharmacy White Space Global Telemedicine Market 70% of retail prescription drug market Online prescription drug market Rapid indus

  7. Slide 7: Multiple Sector Tailwinds Fueling Rapid Growth

    Multiple Sector Tailwinds Fueling Rapid Growth NASDAQ:LFMD Market & Regulatory Changes Have Propelled Telemedicine & DTC Online Pharmacy to New Heights Market Trend Key Factors Implications for LifeMD Rise of high deductible health plans (HDHPs) causing Increased demand for direct-to-consumer models

  8. Slide 8: LifeMD Technology Platform

    LifeMD Technology Platform NASDAQ:LFMD Scalable & Proprietary Digital Health Platform § Vertically integrated, cloud-based technology platform enabled fluid connectivity between patient, physician and pharmacy across all 50 Vertically Integrated states. Platform § Designed to ensure maximum stakehol

  9. Slide 9: LifeMD Patient Journey

    LifeMD Patient Journey NASDAQ:LFMD Seamless Virtual Patient Experience, from Customer Acquisition to Consultation & Rx Delivery 1 - Patient Acquisition Patient/customer views online ad, visits our website, completes medical intake form or purchases. 7- Follow Up 2 - Screening Rx refills, follow up c

  10. Slide 10: Strong Financial Performance

    Strong Financial Performance NASDAQ:LFMD Customer Base & Recurring Revenue from Subscriptions Continues to Scale $60.7M 114% Annual Revenue Growth Annualized Net Revenue CAGR $60.7M Revenue Run-Rate 2018 - 2020P2 & Growing1 0P 02 -2 $38.0M 18 20 $26M 250,000+ R AG C Annual Recurring Patients % 114 R

  11. Slide 11: Expanding Catalogue of Direct-to-Patient Brands

    Expanding Catalogue of Direct-to-Patient Brands NASDAQ:LFMD Diversified Portfolio of Innovative, High-Growth DTC Brands in Large & Attractive Markets Current Brand Portfolio Near Term Launches Shapiro MD™ Rex MD™ Nava MD™ LifeMD™ Telemedicine brand for male Telemedicine brand for men, Teledermatolog

  12. Slide 12: Shapiro MD

    NASDAQ:LFMD Shapiro MD™ Leading hair loss telemedicine brand for men and women. Combines a patented portfolio of OTC and prescription hair loss products with virtual medical treatment in all 50 states. § Developed by distinguished dermatologists, Dr. Steven Shapiro, M.D. and Dr. Michael Borenstein,

  13. Slide 13: Rex MD

    Rex MD™ NASDAQ:LFMD Digital health clinic for men. Initially focused on erectile dysfunction (ED) treatment, Rex MD will soon offer virtual medical treatment for hair loss, skincare, mental health, insomnia, and more. § Launched Dec. 2019 with virtual treatment for erectile dysfunction in 46 states;

  14. Slide 14: Nava MD Launching Q1 2021

    NASDAQ:LFMD Nava MD™ Launching Q1 2021 Online skincare and telehealth brand offering teledermatology in all 50 states. § Teledermatology market expected to grow at 24.3% CAGR to $44.9 billion by 2027. § Dermatology offering supported by Restorsea, a recently in-licensed OTC skincare technology platf

  15. Slide 15: LifeMD

    NASDAQ:LFMD LifeMD™ Subscription-based primary & concierge care designed to transform all aspects of our patients’ long term healthcare needs — “Like having a doctor in the family.” § U.S. primary care market at $296 billion, growing 4.7% annually.1 § LifeMD to offer virtual & on-demand access to a

  16. Slide 16: Proven Management Team

    Proven Management Team NASDAQ:LFMD Leadership Team of Industry Experts with a Track Record of Executing Growth Strategies and Fostering a Culture of Constant Innovation Justin Schreiber Marc Benathen Stefan Galluppi Brad Roberts Dr. Tony Puopolo Corey Deutsch Nick Alvarez Bryant Hussey Chief Executi

  17. Slide 17: Current & Near-Term Addressable Markets

    Current & Near-Term Addressable Markets NASDAQ:LFMD LifeMD’s Current and Future End Markets are Large & Underpenetrated Current Near-Term Launches Herpes & Compound Primary OTC ED & PE Hair Loss Cold & Flu Allergies Testosterone Dermatology Other Cold Sores Topical Rx Care Skincare Market Size $6B $

  18. Slide 18: Competitive Landscape

    Competitive Landscape NASDAQ:LFMD DTC Telemedicine & Online Pharmacy Market are in the Early Innings with Only a Handful of Differentiated Competitors LifeMD Demonstrates Competitive Differentiation Across Several Key Value Drivers Traditional Low Cost Retail B2B2C High Value Pharmacy Competitor Tel

  19. Slide 19: Key Growth Drivers Capitalize on Early Mover Advantage

    Key Growth Drivers Capitalize on Early Mover Advantage NASDAQ:LFMD LifeMD has Sustainable Growth Opportunities in both Current & Adjacent Markets § Current brands: § Continue to penetrate substantial market white-space. $600B Total Addressable § Advance cross-sell capabilities. Market Opportunity wi

  20. Slide 20: 2020 in Review

    2020 in Review NASDAQ:LFMD § Telehealth infrastructure built-out in 2019 a major growth driver in 2020. Revenue Growth § 2020 revenue expected up more than 3x to $38.0M (est.). $60.7M § Launched new teleheath platform, Veritas MD. § Introduced new subscription-base revenue model for Rex MD and Shapi

  21. Slide 21: LifeMD Key Takeaways

    LifeMD Key Takeaways NASDAQ:LFMD Annual Revenue Growth § Fast-growing industry leader in direct-to-patient telehealth. $60.7M § Seamless, end-to-end virtual healthcare solution for patients across all 50 states. § Full range of proprietary telehealth brands & telemedicine services. $38.0M § Growing

  22. Slide 22: Contact Us

    NASDAQ:LFMD Contact Us Company Contact Investor & Media Contact Justin Schreiber Ron Both or Grant Stude President & CEO CMA Investor Relations justin@lifemd.com investors@lifemd.com Tel (949) 432-7566 Corey Deutsch Chief Business Officer Cdeutsch@lifemd.com LFMD lifemd.com 22

  23. Slide 23: Appendix

    LifemMD’ NASDAQ:LFMD Appendix

  24. Slide 24: PDF Simpli

    PDF Simpli NASDAQ:LFMD PDF Simpli is a Valuable Source of Liquidity as well as Digital Marketing and Knowledge Capital for LifeMD § LifeMD owns 82.6% of PDF Simpli through a strategic Differentiators & Value Proposition investment in June 2018. Convert Anywhere, Anytime: Convert PDFs to Word § Cloud

  25. Slide 25: Management, Board of Directors and Advisors

    Management, Board of Directors and Advisors NASDAQ:LFMD Board of Directors Justin Schreiber Chairman John R. Strawn, Jr. Director Management team and board brings LifeMD Roberto Simon Director significant experience in retail, healthcare, e- Dr. Connie Mariano Director commerce, M&A, regulatory and

LifeMD — Investor Presentation (February 2021) on 6ix